Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Income Tax Income Tax + HC Income Tax - 2024 (8) TMI HC This

  • Login
  • Cases Cited
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2024 (8) TMI 517 - HC - Income Tax


Issues Involved:
1. Deletion of the addition under Section 68 by ITAT.
2. Interpretation and application of Explanation 3 of Section 147 of the Income Tax Act, 1961.
3. Reliance on the case of Ranbaxy Laboratories Ltd. by ITAT.
4. Validity of additions based on information from the Investigation Wing.
5. Connection of the addition with the reasons for reopening the assessment.

Issue-wise Detailed Analysis:

1. Deletion of the Addition under Section 68 by ITAT:
The appellant challenged the ITAT's decision to delete the addition of Rs. 58,18,50,000/- under Section 68 of the Income Tax Act. The ITAT upheld the CIT(A)'s order, which concluded that the Assessing Officer (AO) could not make additions on grounds not forming part of the reasons recorded for reopening the assessment. The ITAT observed that the reopening was based on information about accommodation entries from TVH Trading Company Pvt. Ltd. amounting to Rs. 26,40,00,000/-, which had already been added in a previous order. The addition of Rs. 58,18,50,000/- pertained to amounts received from five persons, which were not part of the reasons for reopening.

2. Interpretation and Application of Explanation 3 of Section 147:
The appellant argued that Explanation 3 of Section 147 empowered the AO to assess or reassess income in respect of any issue that comes to his notice during the proceedings, even if not included in the reasons recorded under Section 148. The Tribunal, however, relied on the judgment in Ranbaxy Laboratories Ltd. v. Commissioner of Income-tax, which held that once the principal grounds for reassessment are dropped, no further additions can be made by invoking Explanation 3.

3. Reliance on the Case of Ranbaxy Laboratories Ltd. by ITAT:
The ITAT's reliance on the Ranbaxy Laboratories Ltd. case was contested by the appellant, who argued that the facts of the current case were different. The Tribunal, however, found the principles laid down in Ranbaxy Laboratories Ltd. applicable, noting that once the primary grounds for reopening are dropped, further additions cannot be made. This position was reaffirmed by the High Court, which cited its recent decision in ATS Infrastructure Limited, reiterating that the AO's power to reassess is confined to the issues forming the basis for reopening.

4. Validity of Additions Based on Information from the Investigation Wing:
The appellant contended that the additions were based on concrete information from the Investigation Wing, not on roving and fishing enquiries. The Tribunal, however, found that the addition of Rs. 58,18,50,000/- was unrelated to the reasons recorded for reopening the assessment, which were based on accommodation entries from TVH Trading Company Pvt. Ltd. The High Court upheld this view, emphasizing that the AO cannot make additions on grounds not forming part of the reasons for reopening.

5. Connection of the Addition with the Reasons for Reopening the Assessment:
The appellant argued that the addition related to accommodation entry in the form of share premium was connected to the reasons for reopening the assessment. The Tribunal, however, found no such connection, noting that the addition pertained to amounts from five different persons not mentioned in the reasons for reopening. The High Court upheld this finding, reiterating that the AO's power to reassess is limited to the issues forming the basis for reopening.

Conclusion:
The High Court dismissed the appeal, holding that the ITAT did not err in deleting the addition under Section 68. The Court affirmed that once the primary grounds for reopening the assessment are dropped, no further additions can be made by invoking Explanation 3 of Section 147. The reliance on the Ranbaxy Laboratories Ltd. case was found appropriate, and the Tribunal's conclusions were upheld. The appeal was thus dismissed.

 

 

 

 

Quick Updates:Latest Updates